Recombinant antigen BcMSA1 for Babesia canis

Babesia canis

Merozoite surface antigen (BcMSA1) was described as a potential candidate for babesiosis serodiagnosis, evaluated by ELISA.

Recombinant antigen for the diagnosis of Babesiosis (or piroplasmosis), an animal infectious disease (mainly dogs).

or
Name
BcMSA1
Description
Merozoite Surface Antigen
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0020 (B. canis) P. pastoris WB, DB, IE, DE, CLIA, LF Immunoassay blocker - Example of a certificate of analysis Material Safety Data Sheet
RAG0020BIOT (B. canis, biotinylated) P. pastoris WB, DB, CE, NP, PO Immunoassay blocker - Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Immunoassay blocker Due to the nonspecific interaction with anti-CCDs present in normal human or animal sera, we strongly recommend using our blocker SOR0001 on the analyzed sera in any immunoassay.
Monobiotinylated
This protein is available monobiotinylated
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related proteins
Bc28.1 BcSA1 ChimBc ChimBg

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Recombinant antigens for infectious diseases

How to reconsitute lyophizated vials

Recombinant antigens for diagnosis of Babesiosis

How to use the inmunoassay blocker for anti-cross-reactive carbohydrate determinants (CCD) antibodies